| 0000-00-00 |
|
|
|
External link to document |
| 2021-12-13 |
103 |
|
Products (Nov. 2003, Rev. 2; and (5) U.S. Patent No. 8,568,747 B1. A POSA would
be motivated to combine…Products (Nov. 2003, Rev. 2; and (5) U.S. Patent No. 8,568,747 B1. A POSA would
be motivated to combine…. Del.).
5
U.S. Patent Nos. 11,040,023 (“’023 patent”) and 11,141,405 (“’405 patent”) (collectively, …for patent infringement of United States Patent Nos.
11,040,023 (the “’023 patent”) and…“’405 patent”)
(collectively the “Patents-in-Suit”) and damages under the patent laws
|
External link to document |
| 2021-12-21 |
109 |
|
6/2012
Nov. 2, 2017, now Pat. No. 10,039,745, which is a WO WO-2014055667 …Reference-based pricing of prescription drugs:
10,039,745 B2 8/2018 Mosher … O
U.S. Pat. No. 10,039,745, issued Aug. 7, 2018), which is a …action for patent infringement of United States Patent Nos.
11,040,023 (the “’023 patent”) and 11,141,405…11,141,405 (the “’405 patent”) (collectively the
“Patents-in-Suit”) and damages under the patent laws of the |
External link to document |
| 2022-02-24 |
137 |
Redacted Document |
Thereafter, U.S. Patent Nos.
9,808,442 B2 (“’442 patent,” 18-1962 D.I. 1-1, Compl. Ex. B), 10,039,745 B2 (“’745… or more claims of U.S. Patent No. 11,040,023 (the “’023 patent”) (the “Patent-
In-Suit”). Upon information….S. Patent Application No. 17,228,024, which
issued as U.S. Patent No. 11,141,405 (“’405 patent”) on…and ’987 patents are patentably indistinct from, and
cover essentially the same patentable subject matter…, the ’008 patent.
123. The claims of the Second Wave Patents are patentably indistinct |
External link to document |
| 2022-03-24 |
149 |
Opening Brief in Support |
U.S. Patent No. 10,039,745 (Aug. 7, 2018)
’442 Patent U.S. Patent No. 9,808,442… for Patents)
’008 Patent U.S. Patent No. 9,669,008 (Jun. 6, 2017)
’745 Patent … ’008 Patent, ’745 Patent, ’442 Patent, and ’987 Patent
First Suits 18-1962 and 19….S. Patent No. 11,141,405 (Oct. 12, 2021)
Third Patents ’023 Patent and ’405 Patent
Third…2017)
’987 Patent U.S. Patent No. 10,154,987 (Dec. 18, 2018)
First Patents |
External link to document |
| 2022-04-21 |
155 |
Answering Brief in Opposition |
Decl. Ex. M)
’745 patent U.S. Patent No. 10,039,745 B2 (D.I. 9-5, 7/13/21 Shrestha…405 patent U.S. Patent No. 11,141,405 B2 (D.I. 1, Compl. Ex. A)
’442 patent … PTO or Patent Office United States Patent and Trademark Office
Second Wave Patents … Abbreviation
’008 patent U.S. Patent No. 9,669,008 B1 (D.I.1 9-3, 7/13… Decl. Ex. C)
’023 patent U.S. Patent No. 11,040,023 B2 (D.I. 89-1, First |
External link to document |
| 2022-04-21 |
157 |
Opening Brief in Support |
asserted U.S. Patent Nos. 9,669,008, 9,808,442, 10,039,745 and 10,154,987
(the “First Patents”). In the …U.S. Patent No. 11,040,023 (the “’023 Patent”) and
U.S. Patent No. 11,141,405 (the “’405 Patent”). D.I.…does not assert any of those patents—only the ’023
Patent and the ’405 Patent. Thus, discovery as to the… this patent infringement action against Bion based on
Bion’s infringement of Azurity’s patents, U.S.…First Patents will necessarily reach
“well beyond what is relevant” to the questions of patent infringement |
External link to document |
